Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

BACKGROUND: Antivascular endothelial growth factor tyrosine kinase inhibitors have been used recently in the treatment of advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC). Off-label sorafenib is used in Turkey with special permission by the Ministry of Health for this...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Benekli, Mustafa, Yalcin, Suayib, Ozkan, Metin, Elkiran, Emin Tamer, Sevinc, Alper, Cabuk, Devrim, Coskun, Hasan Senol, Oksuzoglu, Berna, Bayar, Banu, Akbulat, Akif, Ozet, Ahmet
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4271783/
https://ncbi.nlm.nih.gov/pubmed/25548522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S70670
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados